Navigation Links
Amsterdam Molecular Therapeutics Part of Next Biotech Index
Date:4/8/2008

AMSTERDAM, The Netherlands, April 8 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, is, as of today, part of the newly created Next Biotech Index of NYSE Euronext. "We are pleased that NYSE Euronext has selected our company for this index," said Ronald Lorijn, CEO of AMT. "The index will increase the visibility of listed biotech companies and will help investors to track the performance of our sector."

The index is published daily on http://www.euronext.com as well as major data vendors. The ticker symbol is BIOTK.

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of rare (orphan) diseases that are caused by one faulty gene. AMT currently has a product pipeline with six products at different stages of development.

Certain statements in this press release are "forward-looking statements" including those that refer to management's plans and expectations for future operations, prospects and financial condition. Words such as "strategy," "expects," "plans," "anticipates," "believes," "will," "continues," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning are intended to identify such forward-looking statements. Such statements are based on the current expectations of the management of Amsterdam Molecular Therapeutics only. Undue reliance should not be placed on these statements because, by their nature, they are
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board
2. Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board
3. Amsterdam Molecular Therapeutics Reports Full Year Results 2007
4. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
5. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
6. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
7. Molecular Vision and Acrongenomics Unable to Reach Agreement on the Acquisition of Molecular Vision
8. Roche Molecular Diagnostics Invests $57.5 Million in Green Research Building
9. ABR-Affinity BioReagents to Exhibit at the Society for Biomolecular Sciences in St. Louis, April 6 - 10, 2008
10. Sigma-Aldrich Partners With Sunset Molecular Discovery to Expand Your Favorite Gene Search Tool
11. Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...November24/PRNewswire-FirstCall/--deCODE,genetics,...fits,"firstday"motionsbytheU.S.BankruptcyCourtfort...lastweekfiledavoluntarypetitionfor,reliefunderChap...ptcyCourt. , TheordersissuedbytheBankruptcyCo...uringtheChapter11proceedings.Inparticular,the,comp...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq:...ngandcommercializingnovelpainmanagementtherapies,a...xecutiveOfficer,isscheduledtopresentatthe21stAnnua...1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork. ...Officer,willbeavailabletorespondtoquestionsduringt...
(Date:11/24/2009)...ewswire/--BlueMarbleEnergyCorp.announcedtodaythatt...DA)wererecentlyawarded$2millionbyWashingtonState,s...te/publicpartnershiptoconstructthestate,sfirstspec..., "Thisinvestmentwillsignificantlyspeedthedevelop...lnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."Wea...
(Date:11/24/2009)...pointhasbeenmetforpatientswithadvanced-stage,orrec...PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ: ...calcompanyfocusedonendocrinetherapyandoncology,tod...hitstargetedcytotoxicpeptideconjugate,AEZS-108(for...metrialcancer.Inapersonalizedhealthcareapproach,th...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
... Wis. - Acknowledging that a return to profitabil...lthcare reported an annual net loss of $258.5 mil...006 that saw several executives resigned in the wa...ch included a goodwill impairment, trade name impa..., or $6.85 per share, compares to a net loss of $2...
...s. - State Senator Robert Cowles admitted his c...he worst news about the state of Wisconsin,s infor...ut in anticipation of the Legislative Audit Burea...colleague and a software executive, isn`t sure the...on is that the audit on state IT projects should b...
...rted this column just over four years ago, I had n...ar. My interest in writing a column was to share w...unity information that I thought would help them w...l awareness about life science in the Midwest. , ...ed that I couldn,t afford the kind of market resea...
Other Biology Technology:Merge Healthcare suffers $258M loss in `06 2Is the worst over for state technology failures? 2A Midwest life-science odyssey comes full circle 2A Midwest life-science odyssey comes full circle 3A Midwest life-science odyssey comes full circle 4A Midwest life-science odyssey comes full circle 5A Midwest life-science odyssey comes full circle 6A Midwest life-science odyssey comes full circle 7A Midwest life-science odyssey comes full circle 8
(Date:11/23/2009)...iated strain of the deadly superbug MRSAan infecti...ioticsposes a far greater health threat than previ...according to a study in the December issue of Eme... easily picked up in fitness centers, schools, and... burden of MRSA within hospitals, the report found...
(Date:11/23/2009)...ests that a common oral bacterium may exacerbate a...et al, "Unique Lipids from a Common Human Bacteriu... Enhancing Autoimmunity," appears in the December ... , Multiple sclerosis (MS), a disease where the ...ffects nearly 1 in 700 people in the United States...
(Date:11/23/2009)...University of Alabama at Birmingham (UAB) research...ng medical conditions (co-morbidity) do not explai...ericans compared to Caucasians who also have colon... Cancer , a journal of the American Cancer Society...co-morbidity are independent predictors of poor su...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 1Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 2Nepali Home Minister Commends Narconon International for Saving Lives 56495 1Nepali Home Minister Commends Narconon International for Saving Lives 56495 2The Dr Oz Show Names Core Team Oz 56493 1The Dr Oz Show Names Core Team Oz 56493 2The Dr Oz Show Names Core Team Oz 56493 3The Dr Oz Show Names Core Team Oz 56493 4
...the growth and development of plants, but what eff...aper by Nathalie Hoang et al., published in PLoS ...ining cryptochromes in flies, mice, and humans. In...which absorb and process blue light for functions ... stem expansion. Cryptochromes are present in huma...
...--In a breakthrough scientific study published tod...Sciences , scientists at the Burnham Institute for... development may be linked to Autism. The study de...factor 2C (MEF2C) protein in neural stem cells had...viors similar to those seen in humans with a form ...
...move that promises to change the economics of biod...ity have unveiled a set of techniques for cleanly ...ls that fetch a profit. , The latest research is ...ring . The new paper and others published earlier ... allows E. coli and other enteric bacteria to co...
Other Biology News:A mammalian clock protein responds directly to light 2Researchers link early stem cell mutation to autism 2Research yields pricey chemicals from biodiesel waste 2Research yields pricey chemicals from biodiesel waste 3
EasySep Mouse Combo Starter, Kit from StemCell Technologies, Inc.
...purified RNA samples., , This product has been...mples that have been pre-purified using traditiona...lica, oligo dT etc or other kits. , Our StabMRT ...stabilization of nanogram to milligram quantities ...
pORF-eSEAP from InvivoGen
Columbus from Tecan
Biology Products: